Michael Gutch
-
PhaseBio Closes Refinancing With AstraZeneca To Further Drug Trials
PhaseBio Pharmaceuticals, Inc. of Malvern has closed a $40 million Series C financing round led by AstraZeneca. The clinical-stage biopharmaceutical firm is focused on biopolymer-based…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
